A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/18 (2006.01) A61L 24/10 (2006.01)
Patent
CA 2691024
The present invention relates, in general, to fibrin sealants, which contain platelet derived growth factor (PDGF) for controlled release in situ for therapeutic applications, including musculoskeletal disorders, soft tissue disorders and vascular diseases. The present invention relates, in general, to fibrin sealants, which contain platelet derived growth factor (PDGF) for controlled release in situ for therapeutic applications, including musculoskeletal disorders, soft tissue disorders and vascular diseases.
De manière générale, la présente invention concerne des mastics de fibrine qui contiennent un facteur de croissance plaquettaire (PDGF) pour libération régulée in situ à des fins d'application thérapeutique, y compris des troubles musculosquelettiques, des troubles des tissus mous et des maladies vasculaires.
Catelas Isabelle
Donovan Shane
Dwyer Joseph
Helgerson Sam L.
Seyton Wanda
Baxter Healthcare S.a.
Baxter International Inc.
Sim & Mcburney
LandOfFree
Fibrin gel for controlled release of pdgf and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fibrin gel for controlled release of pdgf and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibrin gel for controlled release of pdgf and uses thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1499316